Gefitinib for EGFR Sensitive Mutation Postoperative Stage Ib NSCLC Patients
Clinical trial NCT02526537 · TERMINATED
Trial details
- NCT number
- NCT02526537
- Sponsor
- Lunxu Liu
- Status
- TERMINATED
- Study type
- OBSERVATIONAL
- Start date
- 2015-11-11
- Primary completion
- 2016-06-07
- Enrollment
- 10
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.